Skip to main content

Melox

NDC 27854-117 · Belmora LLC

Generic nameAluminum hydroxide, Magnesium hydroxide, Simethicone
Dosage formLIQUID
RouteORAL
Active ingredient(s)ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DIMETHICONE
Strength400; 40; 400 mg/10mL; mg/10mL; mg/10mL
Pharmacologic classCalculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
Marketing categoryOTC MONOGRAPH DRUG

Packages

27854-117-01 — 355 mL in 1 BOTTLE (27854-117-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

21130-614 — famotidine, calcium carbonate and magnesium hydroxide, 21130-629 — aluminum hydroxide, magnesium hydroxide, dimethicone, 21130-649 — magnesium hydroxide, 21130-691 — aluminum hydroxide, magnesium hydroxide, dimethicone, 21130-717 — Simethicone, 21130-786 — Famotidine, Calcium Carbonate, Magnesium Hydroxide, 21130-898 — Dimethicone, 24286-1533 — Simethicone, 24385-118 — DIMETHICONE, 27854-115 — Aluminum hydroxide, Magnesium hydroxide, Simethicone, 29485-6522 — famotidine, calcium carbonate, and magnesium hydroxide tablet, chewable, 30056-006 — Dimethicone, 30142-040 — famotidine, calcium carbonate and magnesium hydroxide, 30142-213 — Famotidine, Calcium Carbonate, Magnesium Hydroxide, 30142-547 — Magnesium hydroxide, 30142-581 — Loperamide Hydrochloride, Simethicone, 30142-610 — aluminum hydroxide and magnesium carbonate, 30142-619 — Dimethicone, 30142-637 — aluminum hydroxide, magnesium hydroxide, dimethicone, 30142-638 — aluminum hydroxide, magnesium hydroxide, simethicone, +770 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels